James Shin
Stock Analyst at Deutsche Bank
(2.61)
# 2,242
Out of 4,996 analysts
22
Total ratings
50%
Success rate
7.01%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Shin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Maintains: Buy | $1,010 → $900 | $724.54 | +24.22% | 5 | Aug 11, 2025 | |
| IMTX Immatics | Initiates: Buy | $10 | $7.70 | +29.87% | 1 | May 28, 2025 | |
| GILD Gilead Sciences | Upgrades: Buy | $80 → $120 | $112.10 | +7.05% | 2 | Feb 18, 2025 | |
| MRK Merck & Co. | Downgrades: Hold | $128 → $105 | $78.56 | +33.66% | 2 | Feb 18, 2025 | |
| AMGN Amgen | Reiterates: Hold | $310 → $305 | $272.98 | +11.73% | 2 | Aug 7, 2024 | |
| INCY Incyte | Maintains: Hold | $55 → $60 | $82.70 | -27.45% | 2 | Aug 1, 2024 | |
| BMY Bristol-Myers Squibb Company | Maintains: Hold | $53 → $45 | $44.12 | +1.99% | 3 | Jul 23, 2024 | |
| LEGN Legend Biotech | Initiates: Buy | $60 | $33.37 | +79.80% | 1 | May 23, 2024 | |
| ABBV AbbVie | Initiates: Hold | $150 | $220.61 | -32.01% | 1 | Nov 9, 2023 | |
| REGN Regeneron Pharmaceuticals | Initiates: Hold | $800 | $563.90 | +41.87% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.56 | +541.03% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.89 | +1,253.49% | 1 | Nov 9, 2023 |
Eli Lilly and Company
Aug 11, 2025
Maintains: Buy
Price Target: $1,010 → $900
Current: $724.54
Upside: +24.22%
Immatics
May 28, 2025
Initiates: Buy
Price Target: $10
Current: $7.70
Upside: +29.87%
Gilead Sciences
Feb 18, 2025
Upgrades: Buy
Price Target: $80 → $120
Current: $112.10
Upside: +7.05%
Merck & Co.
Feb 18, 2025
Downgrades: Hold
Price Target: $128 → $105
Current: $78.56
Upside: +33.66%
Amgen
Aug 7, 2024
Reiterates: Hold
Price Target: $310 → $305
Current: $272.98
Upside: +11.73%
Incyte
Aug 1, 2024
Maintains: Hold
Price Target: $55 → $60
Current: $82.70
Upside: -27.45%
Bristol-Myers Squibb Company
Jul 23, 2024
Maintains: Hold
Price Target: $53 → $45
Current: $44.12
Upside: +1.99%
Legend Biotech
May 23, 2024
Initiates: Buy
Price Target: $60
Current: $33.37
Upside: +79.80%
AbbVie
Nov 9, 2023
Initiates: Hold
Price Target: $150
Current: $220.61
Upside: -32.01%
Regeneron Pharmaceuticals
Nov 9, 2023
Initiates: Hold
Price Target: $800
Current: $563.90
Upside: +41.87%
Nov 9, 2023
Initiates: Buy
Price Target: $10
Current: $1.56
Upside: +541.03%
Nov 9, 2023
Initiates: Buy
Price Target: $12
Current: $0.89
Upside: +1,253.49%